Cost-effective prescribing of proton pump inhibitor therapy: an audit in general practice

• Published in: International journal of clinical practice (Esher) Vol. 54; no. 5; p. 287
• Main Authors: Cooper, A L, Langworthy, H, Porter, S
• Format: Journal Article
• Language: English
• Published: England 01.06.2000
• Subjects: Adolescent; Adult; Aged; Antacids - economics; Child; Child, Preschool; Cost-Benefit Analysis - statistics & numerical data; Drug Costs; Drug Utilization - economics; Dyspepsia - drug therapy; Dyspepsia - economics; Dyspepsia - etiology; Family Practice - economics; Humans; Medical Audit; Middle Aged; Proton Pump Inhibitors; Proton Pumps - economics; United Kingdom
• ISSN: 1368-5031
• DOI: 10.1111/j.1742-1241.2000.tb11906.x

General practitioners must prescribe cost effectively to control drug expenditure and provide optimal treatment for patients requiring long-term management. An audit was implemented in general practices to review the management of dyspepsia, improve care, rationalise therapy and reduce costs. Policy included identifying patients receiving proton pump inhibitor (PPI) therapy and changing to low-dose cost-effective therapy. If PPI therapy was not required, patients were changed to antacids, H2 receptor antagonists or no treatment. This was an audit in general practice, not a clinical trial, therefore findings reflect outcomes in normal clinical practice. This paper describes the implementation and findings of the audit between January 1997 and July 1999 in 91 general practices involving 7121 patients. Extrapolation of the results concluded that savings of up to 50,000 Pounds could be made in a practice of 10,000 patients, allowing reinvestment in health improvement plans and optimal care.